{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:03:51Z","timestamp":1791471831821,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ijantimicag.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T17:23:48Z","timestamp":1547141028000},"page":"746-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fluoroquinolone-based versus \u03b2-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"53","author":[{"given":"Michail N.","family":"Mavros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta A.","family":"Theochari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Kyriakidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos P.","family":"Economopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Sava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5905-2695","authenticated-orcid":false,"given":"Matthew E.","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The Surgical Infection Society revised guidelines on the management of intra-abdominal infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0002","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/378702","article-title":"Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections","volume":"37","author":"Solomkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1749-7922-6-7","article-title":"A comprehensive review of abdominal infections","volume":"6","author":"Lopez","year":"2011","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1749-7922-7-36","article-title":"Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study","volume":"7","author":"Sartelli","year":"2012","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0006","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jac\/dkp005","article-title":"Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study","volume":"63","author":"Montravers","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"10.1016\/j.ijantimicag.2019.01.004_bib0007","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0924-8579(12)70007-9","volume":"40","author":"Lee","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0008","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/sur.2011.115","article-title":"Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant Gram-negative bacilli isolated from patients treated on surgical wards","volume":"13","author":"Maraki","year":"2012","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.clinthera.2016.04.035","article-title":"Pathogen prevalence and antimicrobial susceptibility among Enterobacteriaceae causing hospital-associated intra-abdominal infections in adults in the United States (2012\u20132013)","volume":"38","author":"Zalacain","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0010","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0011","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.00956-15","article-title":"Antimicrobial susceptibilities of aerobic and facultative Gram-negative bacilli from intra-abdominal infections in patients from seven regions in China in 2012 and 2013","volume":"60","author":"Zhang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0012","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","article-title":"Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome","volume":"63","author":"Ortega","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0013","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amsu.2014.06.005","article-title":"Antibiotic management of complicated intra-abdominal infections in adults: the Asian perspective","volume":"3","author":"Kurup","year":"2014","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0014","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s100960100581","article-title":"Piperacillin\/tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery","volume":"20","author":"Maltezou","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjsurg.2007.01.023","article-title":"Ertapenem or ticarcillin\/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients","volume":"194","author":"Yellin","year":"2007","journal-title":"Am J Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0016","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.sempedsurg.2014.06.008","article-title":"Intra-abdominal sepsis\u2014epidemiology, aetiology and management","volume":"23","author":"Hadley","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1096\/fj.04-3140lfe","article-title":"From conference abstract to full paper: differences between data presented in conferences and journals","volume":"19","author":"Rosmarakis","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0019","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijantimicag.2019.01.004_bib0020","article-title":"Treatment for peritoneal dialysis-associated peritonitis","author":"Ballinger","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0021","series-title":"Review Manager (RevMan)","year":"2014"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0024","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.sla.0000230024.84190.a8","article-title":"Randomized controlled trial of moxifloxacin compared with piperacillin\u2013tazobactam and amoxicillin\u2013clavulanate for the treatment of complicated intra-abdominal infections","volume":"244","author":"Malangoni","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000658-199603000-00012","article-title":"Results of a randomized trial comparing sequential intravenous\/oral treatment with ciprofloxacin plus metronidazole to imipenem\/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group","volume":"223","author":"Solomkin","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0026","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijantimicag.2012.08.013","article-title":"Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study","volume":"41","author":"De Waele","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0027","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijantimicag.2009.06.022","article-title":"Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections","volume":"34","author":"Solomkin","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0028","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000658-200008000-00016","article-title":"Comparison of intravenous\/oral ciprofloxacin plus metronidazole versus piperacillin\/tazobactam in the treatment of complicated intraabdominal infections","volume":"232","author":"Cohn","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0029","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1179\/joc.2009.21.2.170","article-title":"Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study)","volume":"21","author":"Weiss","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/sur.2006.7.341","article-title":"Comparison of sequential intravenous\/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections","volume":"7","author":"Wacha","year":"2006","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0031","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0924-8579(02)00248-0","volume":"21","author":"Starakis","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/sur.2012.017","article-title":"Prospective, randomized, study of ampicillin\u2013sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections","volume":"14","author":"Chen","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"issue":"6A Suppl","key":"10.1016\/j.ijantimicag.2019.01.004_bib0033","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1016\/S0002-9610(98)00221-9","article-title":"Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem\/cilastatin. Trovafloxacin Surgical Group","volume":"176","author":"Donahue","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0034","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000658-200101000-00013","article-title":"Results of a clinical trial of clinafloxacin versus imipenem\/cilastatin for intraabdominal infections","volume":"233","author":"Solomkin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0035","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1097\/INF.0000000000001910","article-title":"Moxifloxacin in pediatric patients with complicated intra-abdominal infections: results of the MOXIPEDIA randomized controlled study","volume":"37","author":"Wirth","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1749-7922-8-3","article-title":"2013 WSES guidelines for management of intra-abdominal infections","volume":"8","author":"Sartelli","year":"2013","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13017-015-0013-x","article-title":"Benefits of WSES guidelines application for the management of intra-abdominal infections","volume":"10","author":"De Simone","year":"2015","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0038","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00104-008-1484-z","article-title":"Antimicrobial and antimycotic therapy of intra-abdominal infections [in German]","volume":"79","author":"Kujath","year":"2008","journal-title":"Chirurg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0039","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0040","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1056\/NEJMe1503936","article-title":"Antibiotics for abdominal sepsis","volume":"372","author":"Wenzel","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0041","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/sur.2017.084","article-title":"Longer-duration antimicrobial therapy does not prevent treatment failure in high-risk patients with complicated intra-abdominal infections","volume":"18","author":"Hassinger","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0042","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/000313481608200951","article-title":"Patients with risk factors for complications do not require longer antimicrobial therapy for complicated intra-abdominal infection","volume":"82","author":"Rattan","year":"2016","journal-title":"Am Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0043","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/TA.0000000000001019","article-title":"Percutaneously drained intra-abdominal infections do not require longer duration of antimicrobial therapy","volume":"81","author":"Rattan","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/sur.2016.184","article-title":"Age and its impact on outcomes with intra-abdominal infection","volume":"18","author":"Farmer","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/sur.2017.235","article-title":"Short-course antimicrobial therapy does not increase treatment failure rate in patients with intra-abdominal infection involving fungal organisms","volume":"19","author":"Elwood","year":"2018","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0046","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/sur.2013.045","article-title":"Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials","volume":"15","author":"De Waele","year":"2014","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0047","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijantimicag.2018.04.014","article-title":"Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"Tandan","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0048","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/dkf167","article-title":"Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis","volume":"50","author":"Sotto","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0049","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/cid\/cit128","article-title":"Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections","volume":"56","author":"Solomkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2019.01.004_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:52Z","timestamp":1760376832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919300044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0924857919300044"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.01.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone-based versus \u03b2-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}